The Vaccine Partnering Terms and
Agreements report provides comprehensive understanding and unprecedented access
to the vaccine partnering deals and agreements entered into by the worlds
leading healthcare companies.
- Trends in vaccine and adjuvant partnering deals
- Deal terms analysis
- Partnering agreement structure
- Partnering contract documents
- Top deals by value
- Most active dealmakers
- Average deal terms for vaccines
The report provides a detailed
understanding and analysis of how and why companies enter vaccine partnering
deals. The majority of deals are discovery or development stage whereby the
licensee obtains a right or an option right to license the licensors vaccine
technology. These deals tend to be multicomponent, starting with collaborative
R&D, and commercialization of outcomes. The report also includes adjuvant
deals and alliances.
Understanding the flexibility of a
prospective partner’s negotiated deals terms provides critical insight into the
negotiation process in terms of what you can expect to achieve during the
negotiation of terms. Whilst many smaller companies will be seeking details of
the payments clauses, the devil is in the detail in terms of how payments are
triggered – contract documents provide this insight where press releases do
not.
This report contains over 1,500
links to online copies of actual vaccine deals and contract documents as
submitted to the Securities Exchange Commission by companies and their
partners. Contract documents provide the answers to numerous questions about a
prospective partner’s flexibility on a wide range of important issues, many of
which will have a significant impact on each party’s ability to derive value
from the deal.
To Read the Complete Report with TOC
Visit: http://www.marketresearchreports.biz/analysis-details/vaccine-partnering-terms-and-agreements
The initial chapters of this report
provide an orientation of vaccine dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst
Chapter 2 provides an overview of the trends in vaccine
dealmaking since 2007, including details of average headline, upfront,
milestone and royalty terms.
Chapter 3 provides a review of the leading vaccine deals since
2007. Deals are listed by headline value, signed by bigpharma, most active
bigpharma, and most active of all biopharma companies. Where the deal has an
agreement contract published at the SEC a link provides online access to the
contract.
Chapter 4 provides a comprehensive listing of the top 50
bigpharma companies with a brief summary followed by a comprehensive listing of
vaccine deals as well as contract documents available in the public domain.
Where available, each deal title links via Weblink to an online version of the
actual contract document, providing easy access to each contract document on
demand.
Chapter 5 provides a comprehensive and detailed review of vaccine
partnering deals signed and announced since 2007, where a contract document is
available in the public domain. The chapter is organized by company A-Z, stage
of development at signing, deal type (collaborative R&D, co-promotion,
licensing etc), and specific therapy focus. Each deal title links via Weblink
to an online version of the deal record and where available, the contract
document, providing easy access to each contract document on demand.
The report also includes numerous
tables and figures that illustrate the trends and activities in vaccine
partnering and dealmaking since 2007.
In conclusion, this report provides
everything a prospective dealmaker needs to know about partnering in the
research, development and commercialization of vaccine technologies and
products.
Vaccine Partnering Terms and
Agreements is intended to provide the reader with an in-depth understanding and
access to vaccine trends and structure of deals entered into by leading
companies worldwide.
To Buy The Copy of
This Report Visit: http://www.marketresearchreports.biz/analysis/19812
About Us
MarketResearchReports.Biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are especially designed to save time and
money of our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948
